Another coronavirus vaccine in Russia may enter civilian circulation in March

According to a report by the Russian satellite news agency on January 17, Konstantin Chernov, director of development of the Russian Federal Research and Development Research Center for Immunobiological Agents in Chumakov, said that the COVID-19 vaccine developed by the center may enter civilian circulation in March.

At present, the center is completing the second phase of clinical trials of the new vaccine and is testing the effectiveness of inactivated vaccines among volunteers.